Home
>
National Drug Code (NDC)
>
Vimpat
Vimpat - 0131-1810-67 - (lacosamide)
Drug Information of Vimpat
| Product NDC: | 0131-1810 |
| Proprietary Name: | Vimpat |
| Non Proprietary Name: | lacosamide |
| Active Ingredient(s): | 10 mg/mL & nbsp; lacosamide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vimpat
| Product NDC: | 0131-1810 |
| Labeler Name: | Kremers Urban Pharmaceuticals Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022254 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090526 |
Package Information of Vimpat
| Package NDC: | 0131-1810-67 |
| Package Description: | 10 VIAL, GLASS in 1 CARTON (0131-1810-67) > 20 mL in 1 VIAL, GLASS |
NDC Information of Vimpat
| NDC Code | 0131-1810-67 |
| Proprietary Name | Vimpat |
| Package Description | 10 VIAL, GLASS in 1 CARTON (0131-1810-67) > 20 mL in 1 VIAL, GLASS |
| Product NDC | 0131-1810 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lacosamide |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090526 |
| Marketing Category Name | NDA |
| Labeler Name | Kremers Urban Pharmaceuticals Inc |
| Substance Name | LACOSAMIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
